Where does Arcis Biotechnology Holdings Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arcis Biotechnology Holdings Limited ranks #28,117 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arcis Biotechnology Holdings Limited hold?

Arcis Biotechnology Holdings Limited holds 9 US utility patents granted between 2015 and 2021, spanning 8 technology areas.

What is Arcis Biotechnology Holdings Limited's Innovation Score?

Arcis Biotechnology Holdings Limited has an Innovation Score of 23.8 out of 100 (13th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Arcis Biotechnology Holdings Limited's patent grant rate increasing or decreasing?

Arcis Biotechnology Holdings Limited's recent grant velocity is +25% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Arcis Biotechnology Holdings Limited's patents?

Arcis Biotechnology Holdings Limited's patents average 9.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arcis Biotechnology Holdings Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Arcis Biotechnology Holdings Limited

Q: What technology areas does Arcis Biotechnology Holdings Limited focus on?

Arcis Biotechnology Holdings Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 6 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 8 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arcis ranks #28,117 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 8 technology areas.

#28,117
of 49,997 US assignees by volume: 13th percentile
by Innovation Score (23.8/100): 9.8
avg claims per patent: +25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28117 · Foreign Corporation #28,117 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #28,117/49,997
PHOTO-FINISH Arbortech Industries
CPC-NARROW C12N · 8 areas
INNOV-THIN 23.8/100
CLAIMS-PAR 9.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Arbortech Industries Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Arcis Biotechnology… · this assignee

24
3D Lighting… · lowest

7

What this shows Arcis's Innovation Score is 23.8/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Arcis's grants concentrate

Arcis Biotechnology Holdings Limited is a focused PatentsView assignee: 8 CPC subclasses with 66.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2015. By volume, Arcis sits between Arbortech Industries Limited and Arixa Pharmaceuticals, Inc..

Arbortech Industr…

9
Arcbyt

9
Arch Biosurgery

9
Archaius

9
Ardica

9
Arecont Vision

9
Argon

9
Arixa Pharmaceuti…

9
Arcis Biotechnolo… ◀

9

What this shows Arcis holds 9 patents at rank #28,149, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arcis

By rank, the assignees closest to #28,149 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Arcis's primary technology class.

Arcis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Arcis Biotechnology Holdings Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	11.1%
2018	1	11.1%
2019	2	22.2%
2020	4	44.4%
2021	1	11.1%

Which technologies does Arcis Biotechnology Holdings Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#28,117

of 49,997 tracked assignees

Innovation Score

23.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Arcis Biotechnology Holdings Limited's patent record in context - here's where to go next.

Arcis Biotechnology Holdings Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 66.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #28,117 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arcis Biotechnology Holdings Limited against Arbortech Industries Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.